(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.16%) $0.928
(0.23%) $10.87
(0.01%) $0.792
(0.02%) $92.59
-0.44% ¥ 1 809.00
Live Chart Being Loaded With Signals
KYORIN Holdings, Inc., through its subsidiaries, researches and develops, produces, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug for the treatment of asthma; Desalex, an antiallergic agent; Beova, Uritos, and Imidafenacin KYORIN therapeutic agents for overactive bladder; Lasvic, a quinolone synthetic antibacterial agent; Pentasa, a remedy for ulcerative colitis/Crohn's disease; Nasonex, an allergic rhinitis therapeutic agent; and Kipres, a leukotriene receptor antagonist anti-bronchial asthma and allergic rhinitis drug...
Stats | |
---|---|
Today's Volume | 29 500.00 |
Average Volume | 71 307.00 |
Market Cap | 103.92B |
EPS | ¥0 ( 2024-02-05 ) |
Next earnings date | ( ¥0 ) 2024-05-08 |
Last Dividend | ¥32.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 24.35 |
ATR14 | ¥1.661 (0.09%) |
Volume Correlation
KYORIN Holdings, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
KYORIN Holdings, Inc. Correlation - Currency/Commodity
KYORIN Holdings, Inc. Financials
Annual | 2022 |
Revenue: | ¥113.27B |
Gross Profit: | ¥50.17B (44.29 %) |
EPS: | ¥82.44 |
Q3 | 2023 |
Revenue: | ¥32.33B |
Gross Profit: | ¥14.67B (45.37 %) |
EPS: | ¥37.55 |
Q2 | 2023 |
Revenue: | ¥27.08B |
Gross Profit: | ¥11.41B (42.14 %) |
EPS: | ¥18.85 |
Q1 | 2023 |
Revenue: | ¥27.85B |
Gross Profit: | ¥12.23B (43.92 %) |
EPS: | ¥11.81 |
Financial Reports:
No articles found.
KYORIN Holdings, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥20.00 (N/A) |
¥0 (N/A) |
¥32.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥10.00 | 2006-09-26 |
Last Dividend | ¥32.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 35 | -- |
Total Paid Out | ¥862.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.6 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.35 | |
Div. Directional Score | 7.49 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9962.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8977.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
8125.T | Ex Dividend Knight | 2024-02-28 | Annually | 0 | 0.00% | |
7483.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6752.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6136.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
4887.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4091.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3315.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
2395.T | Ex Dividend Junior | 2023-09-28 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0356 | 1.500 | 9.29 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0238 | 1.200 | 9.21 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0339 | 1.500 | -0.735 | -1.102 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.53 | 0.800 | 2.34 | 1.871 | [1 - 3] |
quickRatioTTM | 1.327 | 0.800 | 6.90 | 5.52 | [0.8 - 2.5] |
cashRatioTTM | 0.402 | 1.500 | 8.88 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.116 | -1.500 | 8.06 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 75.14 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 146.46 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 146.46 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.164 | -1.500 | 9.34 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.429 | 1.000 | 6.18 | 6.18 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0408 | 1.000 | -1.185 | -1.185 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.405 | 1.000 | 8.86 | 8.86 | [0.2 - 2] |
assetTurnoverTTM | 0.670 | 0.800 | 8.87 | 7.10 | [0.5 - 2] |
Total Score | 10.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.56 | 1.000 | 7.62 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0339 | 2.50 | -0.472 | -1.102 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 146.46 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.61 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 146.46 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.219 | 1.500 | 5.20 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0702 | 1.000 | -0.745 | 0 | [0.1 - 0.5] |
Total Score | 4.35 |
KYORIN Holdings, Inc.
KYORIN Holdings, Inc., through its subsidiaries, researches and develops, produces, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug for the treatment of asthma; Desalex, an antiallergic agent; Beova, Uritos, and Imidafenacin KYORIN therapeutic agents for overactive bladder; Lasvic, a quinolone synthetic antibacterial agent; Pentasa, a remedy for ulcerative colitis/Crohn's disease; Nasonex, an allergic rhinitis therapeutic agent; and Kipres, a leukotriene receptor antagonist anti-bronchial asthma and allergic rhinitis drug. It also provides Mucodyne, a mucoregulating drug; Montelukast KM, a drug for the treatment of bronchial asthma and allergic rhinitis; GeneSoC, a real-time PCR system; Rubysta, a disinfectant cleaner; Milton, a disinfectant; over-the-counter drugs; prescription medicines and quasi-drugs, diagnostics, and industrial chemicals; and reagents and intermediates. In addition, the company offers subcontracted drug manufacturing services. Further, it is involved in the discovery and evaluation of candidate compounds; and research and analysis of other companies' technologies and collection of information concerning clinical trial. KYORIN Holdings, Inc. was founded in 1923 and is based in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators